Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05859880 · ClinicalTrials.gov registry record · NA
Expressive Writing for Caregivers of Persons With Cancer
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT05859880 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 100 participants.
The verdict
NCT05859880, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test the effects of an expressive writing intervention for caregivers of persons with cancer. The main questions the study aims to answer are: 1. Does participation in a group-based, videoconference-delivered expressive writing intervention improve mood and quality of life for caregivers of persons with cancer? 2. Is greater improvement associated with writing that is more emotionally expressive or personally revealing, or with group-based sessions characterized by certain linguistic features such as greater emotionality? 3. Is benefit greater for certain subgroups of caregivers, such as those who are younger or who identify as female in gender? Participants will be asked to join four videoconference-delivered, group-based expressive writing sessions. This will be done in groups of 4-8 caregivers and led by a trained facilitator. During each session, participants will write about their deepest thoughts and feelings about their loved one's cancer and their experiences as a caregiver. They will then discuss as a group any reactions to the writing process. Participants will be randomly assigned to either active intervention (receiving the intervention as soon as a group is formed) or waitlist control. Researchers will compare active and waitlist control participants on to pre- to post-intervention changes in mood and quality of life.
Interventions
- BEHAVIORAL Expressive writing intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-06-08 |
| Est. Completion | 2025-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05859880
The ClinicalTrials.gov registry entry for NCT05859880 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Expressive writing intervention is the first listed.
NCT05859880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05859880 about?
NCT05859880 is a clinical study titled "Expressive Writing for Caregivers of Persons With Cancer". The goal of this clinical trial is to test the effects of an expressive writing intervention for caregivers of persons with cancer. The main questions the study aims to answer are: 1. Does participation in a group-based, videoconference-delivered expressive writing intervention improve mood and qua...
What is the current status of trial NCT05859880?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2023-06-08. Estimated completion is 2025-04-06.
What interventions are being tested in trial NCT05859880?
The interventions under investigation include: Expressive writing intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05859880?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.